Issuance of Equity Securities

Kerry

16/03/2026 13:33

RNS Number : 8208W

Kerry Group PLC

16 March 2026

 

 

16 March 2026

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP

Regulatory Announcement

Issuance of Equity Securities

In accordance with FCA PRM 1.6.4R, Kerry Group plc (the "Company") announces the allotment and issuance of 156,120 A ordinary shares of €0.125 each between 19 January 2026 and 13 March 2026 (inclusive) to satisfy awards under the Company's employee share plans, and their admission to trading under the Company's existing block admissions of shares for this purpose (as set out in the table below).

1
Details of the Issuer
(a)
Name
Kerry Group plc
(b)
LEI
635400TLVVBNXLFHWC59
2
Details of the Transferable Securities Admitted to Trading
(a)
Name, type and Identification Code
Kerry Group plc
A Ordinary Shares of €0.125 each
IE0004906560
(b)
Regulated Market
London Stock Exchange - Main Market
(c)
Number of Further Securities Issued and Admitted
156,120
(d)
Total Number of Securities Admitted Following Issuance
160,168,441
(e)
Fungibility
Fully fungible with existing A Ordinary Shares
3
Issue and Admission Details
(a)
Dates of Issuance and Admission
Issued 19 January 2026 to 13 March 2026
Admitted under block admissions dated:-
6 February 2025
20 January 2023
(b)
Prospectus Information
Not Applicable

 

END

 

CONTACT INFORMATION
GROUP SECRETARY
Ronan Deasy
+353 66 7182000 | GroupCoSec@kerry.ie
WEBSITE
www.kerry.com


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
IOEFLFFVVAIRLIR